Clinical case of myocardial infarction with unspecified familial hypercholesterolemia

Familial hypercholesterolemia is a hereditary autosomal dominant disease characterized by a violation of cholesterol metabolism. This nosology was first described in the late 1930s by the Norwegian clinician Karl Moeller, he proposed the idea that hypercholesterolemia and tendon xanthomas are associ...

Full description

Bibliographic Details
Main Authors: Natalya G. Lozhkina, Aleksandr N. Spiridonov
Format: Article
Language:Russian
Published: Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics 2022-01-01
Series:Атеросклероз
Subjects:
Online Access:https://ateroskleroz.elpub.ru/jour/article/view/547/491
_version_ 1797963007639158784
author Natalya G. Lozhkina
Aleksandr N. Spiridonov
author_facet Natalya G. Lozhkina
Aleksandr N. Spiridonov
author_sort Natalya G. Lozhkina
collection DOAJ
description Familial hypercholesterolemia is a hereditary autosomal dominant disease characterized by a violation of cholesterol metabolism. This nosology was first described in the late 1930s by the Norwegian clinician Karl Moeller, he proposed the idea that hypercholesterolemia and tendon xanthomas are associated with cardiovascular diseases through the inheritance of a single gene. In 1964, two clinical phenotypes of familial hypercholesterolemia were discovered: heterozygous and homozygous, associated with an unfavorable prognosis. To date, it is known that the long-running process of accumulation of low-density lipoproteins in the intima of blood vessels may not have clinical symptoms for many years due to the developed system of collaterals and the absence of hemodynamically significant stenosis. However, without timely diagnosis and appropriate therapy, this condition inevitably leads to the development of a cardiovascular event. The article presents a clinical case demonstrating the development of myocardial infarction in a patient with a late diagnosis of this disease.
first_indexed 2024-04-11T01:22:43Z
format Article
id doaj.art-563220f10a8f4e768a273f6e198247de
institution Directory Open Access Journal
issn 2078-256X
language Russian
last_indexed 2024-04-11T01:22:43Z
publishDate 2022-01-01
publisher Siberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and Genetics
record_format Article
series Атеросклероз
spelling doaj.art-563220f10a8f4e768a273f6e198247de2023-01-03T11:07:31ZrusSiberian Branch of Russian Academy of Sciences, Research Institute of Internal and Preventive Medicine, branch of the Institute of Cytology and GeneticsАтеросклероз2078-256X2022-01-011747478https://doi.org/10.52727/2078-256X-2021-17-4-74-78Clinical case of myocardial infarction with unspecified familial hypercholesterolemiaNatalya G. Lozhkina0https://orcid.org/0000-0002-4832-3197Aleksandr N. Spiridonov1https://orcid.org/0000-0003-4892-0861Novosibirsk State Medical University Russian FederationResearch Institutе of Internal and Preventive Medicine, Branch of the Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences Russian FederationFamilial hypercholesterolemia is a hereditary autosomal dominant disease characterized by a violation of cholesterol metabolism. This nosology was first described in the late 1930s by the Norwegian clinician Karl Moeller, he proposed the idea that hypercholesterolemia and tendon xanthomas are associated with cardiovascular diseases through the inheritance of a single gene. In 1964, two clinical phenotypes of familial hypercholesterolemia were discovered: heterozygous and homozygous, associated with an unfavorable prognosis. To date, it is known that the long-running process of accumulation of low-density lipoproteins in the intima of blood vessels may not have clinical symptoms for many years due to the developed system of collaterals and the absence of hemodynamically significant stenosis. However, without timely diagnosis and appropriate therapy, this condition inevitably leads to the development of a cardiovascular event. The article presents a clinical case demonstrating the development of myocardial infarction in a patient with a late diagnosis of this disease.https://ateroskleroz.elpub.ru/jour/article/view/547/491familial hypercholesterolemiamyocardial infarction
spellingShingle Natalya G. Lozhkina
Aleksandr N. Spiridonov
Clinical case of myocardial infarction with unspecified familial hypercholesterolemia
Атеросклероз
familial hypercholesterolemia
myocardial infarction
title Clinical case of myocardial infarction with unspecified familial hypercholesterolemia
title_full Clinical case of myocardial infarction with unspecified familial hypercholesterolemia
title_fullStr Clinical case of myocardial infarction with unspecified familial hypercholesterolemia
title_full_unstemmed Clinical case of myocardial infarction with unspecified familial hypercholesterolemia
title_short Clinical case of myocardial infarction with unspecified familial hypercholesterolemia
title_sort clinical case of myocardial infarction with unspecified familial hypercholesterolemia
topic familial hypercholesterolemia
myocardial infarction
url https://ateroskleroz.elpub.ru/jour/article/view/547/491
work_keys_str_mv AT natalyaglozhkina clinicalcaseofmyocardialinfarctionwithunspecifiedfamilialhypercholesterolemia
AT aleksandrnspiridonov clinicalcaseofmyocardialinfarctionwithunspecifiedfamilialhypercholesterolemia